Abstract
P161 Body mass index change in adult patients with cystic fibrosis following the introduction of triple CFTR therapy elexacaftor/tezacaftor/ivacaftor: a regional adult cystic fibrosis centre experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have